Inventor · name-matched record
LIANG YANKE
1 granted patent·4 pending applications·0 citations·filing 2022–2025
1Inventor score
This identity is grouped by exact name match (no disambiguated inventor record was available for these filings) — it may combine same-named inventors.
Top patents by PatentIndex Score
5 records- 0190US2026042782A1Isoindolinone and indazole compounds for the degradation of egfrC4 THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0283US2026015362A1N/o-linked degrons and degronimers for protein degradationC4 THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0381US2026078126A1Bicyclic urea kinase inhibitors and uses thereofBROAD INST INC·Filed 2025·Application pending·0 cites
- 0473US2026015338A1Targeted protein degradationC4 THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0558US12559492B2BRAF degradersC4 THERAPEUTICS INC·Filed 2022·Granted Feb 24, 2026·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when LIANG YANKE files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: exact name match across USPTO filings. How scoring works →